Suppr超能文献

含1,2,4-三唑化合物作为抗癌剂的最新进展

Recent Development of 1,2,4-triazole-containing Compounds as Anticancer Agents.

作者信息

Wen Xiaoyue, Zhou Yongqin, Zeng Junhao, Liu Xinyue

机构信息

The Institute of Infection and Inflammation, China Three Gorges University, Yichang, Hubei 443000, China.

出版信息

Curr Top Med Chem. 2020;20(16):1441-1460. doi: 10.2174/1568026620666200128143230.

Abstract

1,2,4-Triazole derivatives possess promising in vitro and in vivo anticancer activity, and many anticancer agents such as fluconazole, tebuconazole, triadimefon, and ribavirin bear a 1,2,4-triazole moiety, revealing their potential in the development of novel anticancer agents. This review emphasizes the recent advances in 1,2,4-triazole-containing compounds with anticancer potential, and the structureactivity relationships as well as mechanisms of action are also discussed.

摘要

1,2,4-三唑衍生物具有良好的体外和体内抗癌活性,许多抗癌药物如氟康唑、戊唑醇、三唑酮和利巴韦林都含有1,2,4-三唑部分,显示出它们在开发新型抗癌药物方面的潜力。本文综述了含1,2,4-三唑的具有抗癌潜力的化合物的最新研究进展,并讨论了其构效关系及作用机制。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验